Clinical Trials Directory

Trials / Sponsors / Revance Therapeutics, Inc.

Revance Therapeutics, Inc.

Industry · 29 registered clinical trials.

StatusTrialPhaseStarted
CompletedPhase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
Glabellar Frown Lines
Phase 22024-04-08
UnknownTeosyal RHA® Histology and Intradermal Implantation Evaluation Study
Histology
—2021-08-20
CompletedEfficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Phase 22019-12-06
CompletedEfficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treat
Lateral Canthal Lines
Phase 22019-03-11
CompletedEfficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
Frown Lines
Phase 22019-01-24
CompletedDaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
Plantar Fasciitis
Phase 22018-12-31
CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
Upper Limb Spasticity
Phase 22018-12-12
CompletedLong-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolate
Cervical Dystonia
Phase 32018-09-05
CompletedSingle Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
Cervical Dystonia
Phase 32018-06-20
CompletedPhase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Plantar Fasciitis
Phase 22017-06-12
CompletedSafety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Sever
Glabellar Frown Lines
Phase 32016-12-09
CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
Glabellar Frown Lines
Phase 32016-12-08
CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
Glabellar Frown Lines
Phase 32016-12-05
TerminatedDaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Plantar Fasciitis
Phase 22016-11-14
CompletedDose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Torticollis (Spasmodic)
Phase 22015-09-01
CompletedSafety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Skin Aging
Phase 32015-09-01
CompletedSafety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
Hyperhidrosis
Phase 22015-09-01
CompletedEfficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
Glabellar Frown Lines
Phase 22014-12-01
CompletedEfficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Skin Aging
Phase 22013-08-01
TerminatedOpen Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to
Skin Aging
Phase 32013-02-01
CompletedEfficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Skin Aging
Phase 32012-12-01
CompletedSafety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adu
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22010-05-01
CompletedA 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Ad
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22010-04-01
CompletedEfficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22010-01-01
CompletedEfficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22009-08-01
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22009-07-01
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Lateral Canthal Lines
Phase 22009-04-01
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Lateral Canthal Lines
Phase 22009-02-01
CompletedSafety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
Phase 22008-11-01